#229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB

Atherosclerotic cardiovascular disease (ASCVD) represents a ubiquitous, inevitable condition that requires proactive, early-life intervention rather than reliance on traditional 10-year risk calculators. Cholesterol is an essential molecule for cellular function and hormone production, yet its clinical assessment is often flawed by the misclassification of lipoproteins as "good" or "bad." Instead, apoB concentration serves as the most accurate metric for gauging atherogenic risk, as it accounts for the total number of harmful particles. Mendelian randomization studies confirm that apoB is causally linked to ASCVD, whereas traditional lipid panels often fail to capture the true metabolic burden. Effective prevention necessitates aggressive, early reduction of apoB levels—ideally to infantile ranges—to mitigate the long-term progression of arterial plaque, as the disease process often begins decades before clinical symptoms manifest.